Blog posts

One year on – how our researchers have responded to the pandemic

“We’re in this together.” One year ago, on 11th March 2020, the World Health Organization declared COVID-19 a global pandemic.

Back then, little over 100,000 cases had been reported globally. Today that number is 1,000 times greater and growing ceaselessly.

With a barely known virus rippling across the world, so too did fear and uncertainty spread as the WHO Director-General addressed all people and nations to make the declaration. Shifting the focus from COVID-19 to people and unity, Dr Tedros also sparked glimmers of optimism by emphasising that innovation and learning would be integral to saving lives and minimising the impact of the pandemic.

How does branding and pricing affect our spending on over-the-counter drugs?

When we’re having issues with our health, as well as visiting the doctor or hospital, one option we have is purchasing over-the-counter (OTC) medicines to treat ourselves at home.

OTC drugs can be purchased without a prescription from a doctor. They tend to be affordable and have low production costs.

#ForUsByUs – co-designing a mental health solution owned by the Black community 

Growing up in a Caribbean family that had experienced various traumas and challenges, I had some awareness of how mental illness impacted myself and my relatives. However, it wasn’t until I attended a masterclass last year on Black mental health hosted by BAME in Psychiatry & Psychology and the Centre of Pan African Thought that I realised the nuanced challenges faced by members of the Black community. 

Has COVID-19 shifted the dial on digital healthcare?

Health and care organisations have historically lagged behind those in other industries in making the most of digital technologies and data solutions. Yet the rapid onset and escalation of the COVID-19 pandemic has essentially forced organisations to embrace these tools to quickly adapt to new ways of working and delivering their services.

This overhaul of industry norms has led to a number of key questions: how widespread has this adoption been? Which tools and technologies have been implemented, and how have these solutions affected staff productivity and service delivery? What will ‘stick’ after the pandemic ends and we return to some semblance of pre-COVID normality?

Community Makers: Designing for dementia during the COVID-19 pandemic

People with dementia are some of the most vulnerable, most isolated, and least able to adapt. COVID-19 has therefore made our work with Imperial College’s UK Dementia Research Institute Care Research and Technology Centre all the more urgent.

The Centre develops technologies for a smart ‘Healthy Home environment‘, supported by remote clinical monitoring, to improve the lives of people affected by dementia and further our understanding of this common disease.

The technology aims to make an impact in a number of ways, including early identification of infection, preventing falls, understanding the relationship between sleep and dementia symptoms, and predicting and managing agitation and difficult behaviours.

Palliate, a digital tool to support community end-of-life care

The majority of people who die every year would prefer to die at home, yet only about half achieve this.

This is often due to not being able to manage symptoms at the end of life. People often have to wait longer than what feels acceptable to them for district nurses to come and administer injections. When this happens, symptoms can escalate, carers and patients can become distressed and families lose control of the situation.